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Transport of organic anions and cations
in murine embryonic kidney development
and in serially-reaggregated engineered
kidneys
Melanie L. Lawrence, C-Hong Chang & Jamie A. Davies
Centre for Integrative Physiology, The University of Edinburgh.
Recent advances in renal tissue engineering have shown that dissociated, early renogenic tissue from the
developing embryo can self-assemble into morphologically accurate kidney-like organs arranged around a
central collecting duct tree. In order for such self-assembled kidneys to be useful therapeutically or asmodels
for drug screening, it is necessary to demonstrate that they are functional. One of the main functional
characteristics of mature kidneys is transport of organic anions and cations into and out of the proximal
tubule. Here, we show that the transport function of embryonic kidneys allowed to develop in culture follows
a developmental time-course that is comparable to embryonic kidney development in vivo. We also
demonstrate that serially-reaggregated engineered kidneys can transport organic anions and cations
through specific uptake and efflux channels. These results support the physiological relevance of kidneys
grown in culture, a commonly used model for kidney development and research, and suggest that
serially-reaggregated kidneys self-assembled from separated cells have some functional characteristics of
intact kidneys.
T
he mature vertebrate kidney is a highly specialised and complex excretory organ, consisting of many
different cell types, with numerous physiological functions. Murine kidney development begins with forma-
tion of a ureteric bud as a branch from the nephric duct at the caudal end of the embryo. At embryonic day
11.5 (E11.5), the rudimentary kidney is composed of two distinct tissue types, the epithelial ureteric bud sur-
rounded by condensed mesenchyme. Previous work in this laboratory has shown that kidney rudiments at this
stage can be dissociated into a single cell suspension, and these cells can self-assemble into organotypic renal
structures1. Refinement of this technique by serial reaggregation produces ‘‘engineered’’ kidneys that are very
similar, morphologically, to intact kidneys grown in culture2, and further refinement using the Sebinger culture
method3 allows development of physiologically relevant structures such as loops of Henle4. Although serially-
reaggregated embryonic kidneys are morphologically similar to kidneys developing intact in culture, it is not
known if these kidneys are functional in the same way as intact cultured embryonic kidneys, or as embryonic
kidneys in vivo. The ability of separated kidney progenitor cells to self-assemble into functional kidney-like
rudiments centred around a single collecting duct would be of great importance both to regenerative medicine
and for use of cultured or engineered kidneys as a drug screening platform.
The nephrons of mature kidneys in vertebrates represent one of the major excretory routes in the body.
Specialised transporters and efflux pumps at the basolateral and apical sides of the proximal tubules mediate
the transport of organic anions and cations, providing a mechanism for excretion of xenobiotics and endogenous
compounds (reviewed in ref. 5). The functional properties of proximal tubules in adult kidneys have been studied
in many species including human, mouse and rat, with varying degrees of species differences reported. For
example, in humans the primary tubular cation transporter in the kidney is OCT2, located in the proximal
tubules, with OCT1 expression mainly localised to hepatocytes and brain6 whereas, in rodents, both Oct1 and
Oct2 are expressed in the proximal tubules of the kidney and both mediate uptake of organic cations7,8.
Although much is understood about tubular excretory processes in mature animals, less is known about the
development of this transport in the embryo. In rats, transcripts for organic anions transporters (Oats) and
organic cation transporters (Octs) have been shown to be detectable in embryonic stages both in vivo and in
culture9,10, with the transcripts for anion transporters appearing earlier than cation transporters10. Uptake of
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fluorescent anion has also been shown in cultured rodent kidneys at
later stages of development and in cultured recombined rodent kid-
ney tissue9–12. It has also been shown that transcript levels for ion
transporters in vivo increase gradually during development to birth,
and continue to increase postnatally until adulthood13–15. However,
the functional development of transport (both uptake and efflux)
from a temporal aspect has not been previously reported in vivo,
either in cultured rodent embryonic kidneys, or in serially-reaggre-
gated engineered kidneys. Understanding the temporal and spatial
development of tubular function is important for our understanding
of nephron development in embryogenesis, and for understanding
the extent to which serially-reaggregated engineered kidneys, and
murine embryonic kidneys in culture, may be physiologically useful
and relevant as a model system.
Using the Sebinger culture system, which encourages cultures to
grow flat whilst preserving development of renal structures, we have
optimised and developed a panel of live fluorescence-based assays to
test tubular function in cultured embryonic kidneys and in serially-
reaggregated, engineered kidneys. We find that, in agreement with
transcript data from rat embryonic kidneys in vivo10, development of
anion uptake function in mice precedes cation uptake both in cul-
tured kidneys and in vivo and that efflux of anions through the Mrp
family of efflux pumps occurs at a later stage than anion uptake. We
also find that cultured kidneys dissected at E11.5 and placed in cul-
ture continue to develop functional characteristics at roughly the
same rate as kidneys allowed to develop in vivo, supporting their
validity as a relevant model for kidney research. Furthermore, we
find that the tubules of serially-reaggregated engineered kidneys are
able to transport anions and cations in a manner similar to the
mature kidney, supporting their possible use therapeutically or for
pharmacological testing.
Results
Development of assays to test tubular uptake and efflux of organic
ions in cultured embryonic kidneys. In order to investigate the
emergence of tubular function in renal development, we developed
and optimised a series of assays to test tubular transport of organic
anions and cations in live, cultured, developing murine kidneys.
These assays could then be used to test transport function in the
serially-reaggregated, engineered kidneys. Specific inhibitors of the
different transport channels were employed to demonstrate
specificity of fluorescent cation uptake and fluorescent anion
uptake or efflux. The assays (anion uptake, anion efflux and cation
uptake) are summarised in Figure 1.
Assay for Organic Anion Uptake. The fluorescent anion 6-
carboxyfluorescein (6-CF) was chosen as a tracer dye to investigate
organic anion transport in cultured embryonic kidneys and in seri-
ally-reaggregated engineered kidneys. The 376 Dalton fluorescein
derivative 6-CF has been shown to be transported by organic anion
transporters (Oats)9–12. Uptake of organic anions in mice is mediated
by organic anion transporters localized to both the basolateral (Oat1/
3 and Oatp4c1) and apical surfaces (Oat2/5)5,16,17. In addition, Urat1
is located at the apical surface of proximal tubules: Urat1 is, however,
a urate-anion exchanger and is therefore not likely to be relevant to
cultured kidneys because cultured kidneys are not filtering blood or
regulating serum urate levels. 6-CF is also likely to be transported by
the basolaterally-located Oatp4c118, a member of the organic anion
Figure 1 | Transport assays for live whole embryonic kidney culture.
Arrows indicate direction of transport, filled boxes indicate inhibition of
transport. (A) Organic Anion Uptake Assay – (i) The fluorescent anion 6-
carboxyfluorecein (6-CF) is taken up in the tubules of cultured kidneys by
organic anion transporters. Cultured kidneys are either treated with 6-CF
only, or 6-CF plus Oat inhibitor (probenecid, 2.5 mM), and uptake is
allowed to progress for one hour. (ii) Live cultured kidneys are imaged
immediately following treatment of both conditions with probenecid
(10 mM) to inhibit efflux of 6-CF and retain fluorophore intracellularly.
(B) Organic Anion Efflux Assay – The fluorescent anion 6-CF is taken up
by the tubules of cultured kidneys and then exported into the lumen of the
tubules through the Mrp family of efflux pumps and possibly by other
routes. (i) Cultured kidneys are treated with 6-CF for one hour to allow
uptake and then (ii) treated with either digoxin alone (to block Pgp, BCRP
and Oatp4c1), or digoxin plus MK-571, a specific Mrp-family inhibitor.
For clarity only theMrp family is shown. (C) Organic CationUptake Assay
– The fluorescent cation DAPI is taken up in the tubule cells of cultured
kidneys by organic cation transporters. Cultured kidneys are either treated
with DAPI, or with DAPI plus Oct inhibitors (metformin and cimetidine).
All assays are with live cultured embryonic kidneys and imaging is carried
out on live kidneys or serial reaggregates.
www.nature.com/scientificreports
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transport peptide (Oatp) family of anion transporters, which pref-
erentially transport anions over 350 Daltons16.
Probenecid is a potent and broad inhibitor of anion transporters,
including the murine basolateral renal tubular Oat family of anion
transporters19, and the apical Oat2 and Oat 520,21. Since probenecid
inhibits other members of the Oatp family22 it may also be an inhib-
itor of Oatp4c1, although this has not been specifically reported to
our knowledge. In addition, probenecid has been found to inhibit the
apically-located Mrp-family of efflux pumps23,24.
Anion uptake was assessed by incubating live, cultured kidneys
growing in the Sebinger culture system with the fluorescent anion 6-
CF, either with or without probenecid (2.5 mM)19 (Figure 1A). After
allowing uptake to proceed for one hour, both conditions were
treated with a higher concentration of probenecid (10 mM) to block
efflux of 6-CF by the Mrp-family of efflux pumps, and thus to trap
sufficient fluorophore intracellularly for imaging purposes (adapted
from methods by Rosines et al.12, and Rak-Raszewska et al.11).
Assay for Organic Anion Efflux. Efflux of anions into the lumen of the
proximal tubules is mediated by the Mrp family and Breast Cancer
Resistance Protein (Bcrp), and to some extent by P-glycoprotein
(Pgp,Mdr1). Although the basolateral Oatp4c1 is thought tomediate
uptake of anions into the cell18, it is also possible that it may mediate
basolateral efflux as many of the Oatp family are capable of bidirec-
tional transport16.
Fluorescein efflux has been shown to be mediated by the Mrp
family of luminal efflux pumps25,26, which are inhibited by the Mrp
family-specific inhibitor MK-57127. Although efflux of fluorescein or
its derivative 6-CF has not specifically been shown to be mediated by
Pgp, Bcrp or Oatp4c1, we decided to inhibit these routes of efflux to
isolate transport by the Mrp family of efflux pumps.
Digoxin is known to be transported by Oatp4c118, and effluxed
apically into the lumen of the renal tubules by P-glycoprotein
(Mdr1)28. Its use as a competitive inhibitor of Oatp4c1 and Bcrp
transport channels has also been reported18,29. On the other hand,
transport of digoxin by Mrp is minimal in comparison30.
Anion efflux at the apical side was again assessed using the fluor-
escent anion 6-CF. For the efflux assay, both conditions were allowed
to take up 6-CF through the organic anion transporters (Figure 1B
(i)). After allowing uptake of the fluorescent anion 6-CF, live kidneys
in Sebinger culture were washed and treated with digoxin to inhibit
efflux through channels other than Mrps. Treatment with digoxin
was either with or without the Mrp-family-specific inhibitor MK-
57127 in order to test the specificity of anion efflux by this efflux pump
in cultured and engineered kidneys (Figure 1B (ii)).
Assays for Organic Cation Uptake. In addition to anion uptake and
efflux, we investigated the ability of the proximal tubules of cultured
embryonic kidneys to take up organic cations using the fluorescent
cationic molecule 4’,6-diamidino-2-phenylindole (DAPI) (Figure 1C).
DAPI is not normally permeable to live cells with intact cell mem-
branes, however, the dye can be transported into epithelial cells via
Oct1, which is expressed in the kidney in mice31. Uptake of DAPI by
Octs was assessed either with or without the organic cation trans-
porter family inhibitors metformin and cimetidine32–34.
These assays were used as the basis for analysing tubular function
in cultured kidneys and serially-reaggregated engineered kidneys.
Onset of tubular uptake and efflux of anions by organic anion
channels in cultured embryonic kidneys occurs in a temporally
and physiologically relevantmanner.We first assessed qualitatively
the ability of embryonic kidneys, cultured from E11.5, to take up the
fluorescent anion 6-CF specifically in the presence or absence of
probenecid, a well-characterised Oat inhibitor. We found that
cultured embryonic kidneys are able to transport organic anions
early in development (Figure 2). The specific function of anion
transporters appeared as early as 2 days in culture (Figure 2B), at
the earliest stage of nephron formation. This functional aspect of
renal tubules was maintained throughout the culture of the embryo-
nic kidneys, with increasing numbers of developing nephrons
exhibiting specific tubular uptake (Figure 2C). As expected, there
was no evident uptake of the fluorescent anion 6-CF after 1 day in
culture, when nephrons are only beginning to be induced (Figure 2A).
In order to compare the functional onset of anion transport in
kidneys in Sebinger culture to kidneys allowed to develop in vivo, we
analysed transcripts for themain renal anion transporters at different
embryonic time-points, using semi-quantitative multiplex RT-PCR
(Figure 2D). In addition, we also analysed transcripts from cultured,
E11.5 embryonic kidneys that were grown in culture for varying
lengths of time. Transcripts for two of the renal anion transporters,
Oat1 and Oat335,36, were detected at embryonic day 14.5 (E14.5),
while transcript for the basolateral anion transporter Oatp4c1 was
detected from E13.5. In cultured kidneys, transcripts for Oat1 and
Oat3 were detected after 3 days in culture, whilst transcript analysis
for Oatp4c1 showed detectable transcript from the first day in
culture.
Figure 2 | Onset of tubular organic anion uptake in developing kidneys in
culture and in vivo. Specific uptake of the fluorescent anion 6CF with or
without the Oat inhibitor probenecid was investigated in E11.5 mouse
kidneys grown in Sebinger culture after 1 day (A), 2 days (B) or 6 days (C)
in culture. Scale bars represent 300 mm. (D) Total mRNA was extracted
from kidneys at various embryonic stages and from adult murine kidney.
Detection of mRNA transcripts from three renal organic anion
transporters was evaluated by multiplex RT-PCR (gene of interest and b-
actin). (E) Total mRNA was extracted from E11.5 embryonic kidneys
cultured for 1, 2, 3, 4, or 6 days. Detection of mRNA transcripts from three
renal organic anion transporters was evaluated bymultiplex RT-PCR (gene
of interest and b-actin).
www.nature.com/scientificreports
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We next assessed the ability of cultured embryonic kidney tubules
to export organic anions apically into the tubular lumen. After allow-
ing the fluorescent anion 6-CF to be taken up by the tubules in
cultured embryonic kidneys, efflux by the Mrp family was assayed
by treating the live kidneys with digoxin (to eliminate other possible
routes of anion efflux), either with or without theMrp inhibitorMK-
57127.
No efflux of anions by cultured embryonic kidneys was observed
(Figure 3A) before 3 days in culture, from when it increased
(Figure 3B). After 4 days in culture, efflux was clearly apparent except
in kidneys treated with MK-571 (Figure 3C), and efflux mediated
specifically by Mrp transport was maintained after 6 days in culture
and beyond (Figure 3D).
An important Mrp-family efflux pump expressed in the murine
kidney is Mrp2. Transcript analysis of Mrp2 by semi-quantitative
multiplex RT-PCR in embryonic kidneys allowed to develop in vivo
and dissected at different embryonic time-points indicated that the
transcript for Mrp2 can be clearly detected at E15.5 (Figure 3E). In
cultured kidneys, the Mrp2 transcript is apparent from about 3–4
days in culture (Figure 3F).
Onset of tubular uptake of cations by organic cation channels in
cultured embryonic kidneys also occurs in a temporally and
physiologically relevant manner. Proximal tubule epithelial cells
in the kidney in mice also take up organic cations. The onset of
tubular function with respect to uptake of cations in the
developing murine kidney and the extent to which this function is
developed in culture has not been reported.
We assessed qualitatively the ability of embryonic kidneys, also
cultured from E11.5, to specifically take up the fluorescent cation
DAPI in the presence or absence of metformin and cimetidine, inhi-
bitors of the organic cation family of transporters (Octs). DAPI does
not normally penetrate intact membranes of live cells, but can be
transported into cells expressing Oct131. We found that uptake of
DAPI was observed in the tubules of cultured embryonic kidneys
after 4 days in culture (Figure 4B) and this functional characteristic of
the tubules was maintained after 6 days in culture (Figure 4C) and
beyond. In contrast, no specific tubular uptake of DAPI was observed
up to 3 days in culture (Figure 4A). To demonstrate the presence of
(functional) tubules in this assay, we used 6-CF, which is taken up
through the anion channels and therefore unaffected by cation chan-
nel inhibitors (Figure 4A–C bottom panels).
The principal renal organic cation channels found in mice are
Oct1 and Oct237. Transcript analysis of Oct1 and Oct2 by semi-
quantitative RT-PCR in embryonic kidneys allowed to develop in
vivo and dissected at different embryonic time-points indicated that
the transcripts for Oct1 and Oct2 are detectable at E15.5 (Figure 4D).
In cultured kidneys, dissected at E11.5 and cultured for 1, 2, 3, 4 or 6
days, Oct1 transcripts were weakly detected from 3 days in culture
and increased after 4 days in culture (Figure 4E). Oct2 transcript was
weakly detected after 4 days in culture.
Whilst there was clear tubular accumulation of DAPI in cultured
kidneys by 4 days in culture, we observed a small amount of nuclear
DAPI staining outside the tubules in all the kidneys, whether treated
with inhibitor or not, and at all stages (Supplementary Figure S1(A)).
We surmised that these might be apoptotic or dead cells with cell
membranes no longer intact, allowing DAPI to penetrate and bind to
the DNA. To test this, we used the phospholipid-binding protein
Annexin-V, which has high affinity for phosphatidylserine (PS).
Early in apoptosis, PS is translocated from the inner cell membrane
to the outer. Necrotic cells also lose their membrane integrity and
thus PS is also accessible to Annexin in these cells. Fluorescently
labelled Annexin-V can therefore be used to identify apoptotic and
necrotic cells38, so we used Annexin-Cy5 to identify cells whose
membrane integrity had been lost (Figure 5). Almost all the cells that
were DAPI-positive but not within tubules were also labelled for
Annexin-V (shown in red), whether kidneys had been treated with
uptake inhibitor (Figure 5B) or not (Figure 5A). In contrast, tubular
cells that were positive for DAPI were not labelled with Annexin-V.
Serially-reaggregated engineered kidneys exhibit some functional
characteristics of intact cultured kidneys. This laboratory has
previously shown that early murine kidney rudiments comprising
only two tissue types, ureteric bud and metanephric mesenchyme,
are capable of self-assembling into renal structures and progressing
developmentally after dissociation into single-cell suspension1.
Figure 3 | Onset of tubular organic anion efflux in developing kidneys in
culture and in vivo. Specific efflux of the fluorescent anion 6CF with or
without the Mrp family-specific inhibitor MK-571 was investigated in
E11.5mouse kidneys grown in Sebinger culture after 2 days (A), 3 days (B),
4 days (C) or 6 days (D) in culture. Scale bars represent 300 mm. (E) Total
mRNA was extracted from kidneys at various embryonic stages and from
adult murine kidney. Detection ofmRNA transcripts from one of themain
renalMrp efflux pumps (Mrp2) was evaluated bymultiplex RT-PCR (gene
of interest and b-actin). (F) Total mRNA was extracted from E11.5
embryonic kidneys cultured for 1, 2, 3, 4, or 6 days. Detection of mRNA
transcripts from Mrp2 was evaluated by multiplex RT-PCR (gene of
interest and b-actin).
www.nature.com/scientificreports
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Refinement of this technique by serial reaggregation and in Sebinger
culture allows the engineering of a self-assembled kidney organised
around a single collecting duct and with distinct structures such as
loops of Henle, making them morphologically very similar to intact
kidneys grown in culture2,4.
We used the transport assays described above to investigate
whether the tubular epithelia in serially-reaggregated engineered
kidneys are functional. Number of days in culture was counted
beginning from addition of fresh, dissociated mesenchyme to iso-
lated, previously dissociated and now reaggregated ureteric bud cysts
(seeMaterials andMethods). Specific uptake of the fluorescent anion
6-CF by organic anion transporters was observed from 3 days in
culture, with no detectable uptake in serially reaggregated, engi-
neered kidneys treated with the Oat inhibitor probenecid
(Figure 6A). Specific efflux of 6-CF through the Mrp-family of efflux
pumps was also observed from 4 days in culture (Figure 6B), with no
efflux seen after only 3 days in culture, or in cultures treated with the
Mrp-specific inhibitor MK-571. Finally, we investigated whether the
tubular epithelia of serially-reaggregated, engineered kidneys were
capable of cation transport. Cultures were treated with the fluor-
escent cation DAPI with or without the presence of the cation inhi-
bitors metformin and cimetidine. We observed uptake of the
fluorescent cation DAPI into the tubules from 3 days in culture,
but no uptake was observed when the serially-reaggregated engi-
neered kidneys were treated with the Oct inhibitors metformin and
cimetidine (Figure 6C). To demonstrate the presence of (functional)
tubules in the serially-reaggregated kidneys assayed for cation trans-
port function, tubules were also labelled with 6-CF (Figure 6D).
Discussion
Our results demonstrate that tubular transport function begins early
in kidney development in agreement with previous microarray ana-
lyses13, and that cultured embryonic kidneys behave in a similar way
to kidneys allowed to develop in vivowith respect to tubular function.
In addition, we have shown that serially-reaggregated engineered
kidneys also develop this transport function. Whilst basolateral to
luminal transport is an important component of tubular function,
tubules also transport molecules from the tubule lumen that have
passed through the glomerular filtration barrier, and we have not
yet determined if this process is active in cultured or serially-
reaggregated engineered kidneys.
We have shown that transport of organic anions and cations is not
dependent on development of vasculature and glomerular filtration.
There are other examples of the uncoupling of tubular transport
and blood filtration in development, for example in insects, where
the functions take place in different locations in the body39,40. The
Figure 4 | Onset of tubular organic cation uptake in developing kidneys in culture and in vivo. Specific uptake of the fluorescent cation DAPI with or
without the Oct inhibitors metformin and cimetidine was investigated in E11.5 mouse kidneys grown in Sebinger culture after 3 days (A), 4 days (B) or 6
days (C) in culture. Tubules were also labelled by uptake of 6-CF (A–C, bottom panels). Cultures in (A) and (B) were imaged using an epifluorescence
microscope. Cultures in (C) were imaged using a confocal microscope and images shown are of a single confocal plane. Scale bars represent 500 mm.
D) Total mRNA was extracted from kidneys at various embryonic stages and from adult murine kidney. Detection of mRNA transcripts from two renal
murine organic cation transporters was evaluated by multiplex RT-PCR (gene of interest and b-actin). (E) Total mRNA was extracted from E11.5
embryonic kidneys cultured for 1, 2, 3, 4, or 6 days. Detection of mRNA transcripts from two murine renal organic cation transporters was evaluated by
multiplex RT-PCR (gene of interest and b-actin).
www.nature.com/scientificreports
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purpose of basolateral to luminal transport early in the development
of the embryo is unknown: itmay provide an early excretory route for
endogenous compounds and xenobiotics.
Previous work has suggested that anatomically-correct, reaggre-
gated kidneys are able to develop vasculature and to develop some
degree of glomerular filtration41. This study provides evidence that
serially-reaggregated engineered kidneys can also develop the crit-
ically-important function of active transport, making the prospect of
developing engineered kidneys for clinical use or drug screening
more relevant.
Methods
Embryonic Organ Culture. Embryonic kidneys were dissected from E11.5 mouse
embryos and placed in Sebinger culture3, in which they were cultured for up to 10
days. Kidney cultures were incubated in 82–85 ml kidney culture medium (KCM)
(KCM consists of Eagle’s MEMwith Earle’s salts (Sigma, M5650) supplemented with
10% fetal calf serum (Invitrogen, 10108165) and 1% Penicillin/Streptomycin (Sigma,
P4333)). Medium was changed daily.
Formation of Serial Reaggregates (Engineered kidneys). Serial reaggregates were
engineered according to the method described in refs. 1, 2. Briefly, 8–10 kidneys were
dissected from E11.5mouse embryos and pooled. These were trypsinised for 1 min at
37uC before manually dissociating and passing twice through a cell strainer (40 mm
pore size). The dissociated cells were pelleted by centrifuging at 9000 3 g and then
cultured in conventional organ culture system (Isopore filters supported by metal
grids) in KCM. For the first 24 hours media was supplemented with the ROCK
inhibitor glycyl-H1152-dihydrochloride (1.25 mM). After 3–4 days in culture, single
ureteric bud cysts were isolated by dissection and either placed in conventional organ
culture, or placed in Transwell dishes (using Greiner CELLSTARH 6 well plates), and
surrounded by dissected, dissociated and pelleted mesenchyme from 8–10 new E11.5
kidneys. After 24 hours, the aggregated tissue was placed into Sebinger culture and
grown for a further 3, 4 or 6 days.
Chemicals and Reagents. The following reagents were purchased from Sigma
Aldrich; Metformin hydrochloride (PHR1084), Cimetidine (C4522), Probenecid
(P8761), MK-571 (M7571), Digoxin (D6003). 6-carboxyfluorescein was purchased
from Invitrogen (C1360). Glycyl-H 1152 dihydrochloride was purchased fromTocris
(2485). Metformin, cimetidine, and 6-carboxyfluorescein were solubilised in water to
make stock concentrations as follows: metformin 100 mM, cimetidine 25 mM, 6-
carboxyfluorescein 1 mM. Probenecid was solubilised in 500 mM NaOH, to make a
stock concentration of 250 mM. MK-571 and digoxin were solubilised in DMSO to
make stock concentrations as follows: MK-571 10 mM, digoxin 93.5 mM. Reagents
for live assays were diluted in PBS.
Transporter Assays.All assays were carried out on live cultures grown in the Sebinger
culture system. Only cultures that were healthy at the time of assay were used; for
intact, cultured kidneys this was approximately 8 in 10. For serially reaggregated
engineered kidneys this number dropped to approximately 6 in 10. Live staining to
outline morphological structure was done in all cases by incubating cultures, at same
time as the transporter assay, with rhodamine-conjugated peanut aggulutinin
(20 mg/ml Vector Laboratories, RL-1072). Prior to assay all cultures were washed
once in PBS. Specific uptake of anions in the tubules of cultured kidneys was assayed
by incubating live cultures with the fluorescent anion 6-carboxyfluorecein (6-CF)
(1 mM) either with probenecid (2.5 mM), or with vehicle only (final concentration of
NaOH for both conditions, 5 mM) for one hour at 37uC. Cultures were washed once
in PBS and then incubated with probenecid (10 mM) for 15 min at 37uC to trap
intracellular fluorophore before imaging. Anion uptake assays in cultured intact
kidneys were repeated 3 times (1 d), twice (2 d) or 7 times (6 d). Uptake in untreated
kidneys and inhibition of uptake in inhibitor-treated kidneys was evident in every
case. Specific efflux of anions by the Mrp family of efflux pumps was assayed by pre-
loading live cultures with 6-CF for one hour at 37uC (1 mM), washing once in PBS and
imaging briefly to confirm anion uptake, and then subsequently incubating with
either digoxin (500 uM) and vehicle (0.33% DMSO), or digoxin (500 mM) and MK-
571 (30 uM) (final DMSO concentration for both conditions 0.83%), for 30–60 min
at 37uC. Anion efflux assays in cultured intact kidneys were repeated twice (2 d, 3 d)
or 4 times (4 d, 6 d) with efflux in kidneys untreated with MK571, and inhibition of
efflux in MK571-treated kidneys evident in every case. Specific uptake of cations in
the tubules of cultured kidneys was assayed by incubating live cultures with the
fluorescent cation DAPI (1 mM) alone or in the presence of metformin (5 mM) and
cimetidine (200 mM) for 30 minutes at 37uC. Cultures were washed 3x in PBS before
imaging. Because DAPI is bound stably to DNA once inside a cell, the cultured
kidneys could be imaged directly without needing to trap the fluorophore
intracellularly. Cation uptake assays in cultured intact kidneys were repeated twice
(3 d, 4 d) or 10 times (6 d). Uptake in untreated kidneys and inhibition of uptake in
inhibitor-treated kidneys was evident in every case. All assays (uptake and efflux) in
serially-reaggregated kidneys were performed once (3 d, 4 d) or twice (6 d).
Inhibition of uptake or efflux in inhibitor-treated cultures, and no inhibition of
uptake or efflux in untreated cultures, was evident in every case.
Annexin-V staining of live organ cultures. An AnnexinV assay kit was purchased
from Biovision (K103-25). After carrying out the cation transporter assay, live
cultures were washed 3x in PBS and then incubated with AnnexinV binding buffer for
5 min at room temperature. Cultures were then incubated with AnnexinV solution
diluted 15100 in binding buffer at 37uC. Cultures were imaged immediately by
confocal microscopy.
Imaging. Live cultures were imaged using a Zeiss Axiovert epifluorescence
microscope with Axiovision software, or using a Nikon A1R confocal microscope
with NIS elements software. When applicable all images were taken with identical
exposures for comparison. All images were analysed using ImageJ.
Isolation of mRNA and RT-PCR. Total mRNA was isolated from 25–30 pooled
embryonic kidneys, pooled cultured kidneys, or adult kidney using the RNeasy kit
from Qiagen and according to kit instructions. After isolation, purity of RNA and
absence of genomic DNA was confirmed by PCR for b-actin using primers that span
an intron and using RNA preparations made with and without addition of reverse
transcriptase. PCRs for genes of interest were carried out in multiplex reactions with
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